Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Hand and Upper Limb Orthopedic Surgeon Dr. Alejandro Badia offers tips on diagnosing and treating wrist injury


Dr. Alejandro Badia

Specific tests can tell the difference between these types of wrist injuries and point to the right treatment.

You’ve had a fall or mishap and now your wrist really hurts, but is it sprained – or broken? Sometimes it’s difficult to tell, but specific tests can tell the difference between these types of wrist injuries and point to the right treatment, according to orthopedic surgeon Alejandro Badia, MD, founder of Badia Hand to Shoulder Center and OrthoNOW and author of Healthcare from the Trenches.

A complex joint that allows for both front-to-back and side-to-side movement, the wrist is composed of the ends of 2 long arm bones along with 8 small, oval-shaped wrist bones and the bases of each of the 5 fingers. With all of these bones converging in one place, it’s no wonder that the wrist is vulnerable to injury, says Dr. Badia, who specializes in treating injuries of the upper limbs, which include the wrist, hand, fingers, elbow and shoulder.

“Some wrist injuries – say, from a car or sports accident – are obviously more severe than others,” he explains. “But most of us injure our wrists from time to time by tripping and falling. Our wrists aren’t designed to absorb the impact they receive when we try to ‘catch’ ourselves by putting our hands out and landing on them during a fall.”

Telling the difference

If you’ve hurt your wrist but aren’t sure if it’s sprained or broken (also called fractured), you may be wondering what the difference is. Simply put, Dr. Badia says, a sprain means the ligaments supporting the wrist stretch beyond their limits and tear. Meanwhile, a fracture means one or more bones in the wrist have broken.

“Both injuries can produce severe pain, but – contrary to widespread belief – sprains don’t always hurt less than fractures,” he explains, adding that symptoms for both can include:


  • Pain, especially when you move your wrist
  • Swelling in the wrist or hand
  • Difficulty picking up things
  • Limited range of motion
  • Bruising

On the other hand, a broken wrist may provide some nasty clues about its status, as your wrist may appear deformed. “The bone may be pushing against the skin or even poke through it,” Dr. Badia says. “Also, with a break you may hear a snap or pop in your wrist, which will then immediately swell and worsen, even if you put ice on it.”

If you think you’ve fractured your wrist, or even if you suspect a sprain but your pain isn’t quickly improving, it’s time to see a doctor with particular training and expertise in treating wrist problems, to be properly diagnosed, Dr. Badia advises. After an exam, your doctor may order imaging tests such as X-rays, or MRI or CT scans, that can help determine whether you’ve sprained or fractured your wrist.

Treatment tips

After a diagnostic process has revealed a sprain or fracture, a variety of treatments may be recommended, depending on the outcome.

For a sprained wrist, home treatment may include resting the joint for at least 48 hours; applying ice several times a day for 20 minutes at a time; compressing the joint with an elastic compression bandage; and elevating your wrist higher than heart level as often as possible. In most cases a mild wrist sprain will only need compression and ice.

“Moderate sprains might require wearing a wrist splint for a week or more, but you may also be advised to do some stretching exercises when your wrist comes out of the splint to help you regain full range of motion,” he says. “In unusual cases, severe sprains might need surgery to reconnect wrist ligaments to bone or a tendon graft to reconstruct the injured ligament.” Dr. Badia adds that the good news is that in experienced hands, almost all wrist surgery is performed like in the knee with arthroscopy. Two little holes in the wrist allow a fiberoptic camera to refine the diagnosis and then direct treatment through tiny instruments inserted in different sections of the complex wrist joint. This is why it’s important to find the right specialist, one with training and expertise in treating wrists, to assess AND treat your wrist pain.

A broken wrist may be placed in a splint or cast for several weeks to align the broken ends of the bone, Dr. Badia says. But some fractures are also severe enough to require surgery to set correctly.

“If you have a complex or open wrist fracture, a surgeon may need to implant hardware such as pins, rods or screws to hold your bones in place while they heal,” he explains.

With either a sprained or fractured wrist, however, most patients recover fully after a period of immobilizing the injured joint and restoring movement through exercise and rehabilitation afterward.

“It’s important for either type of injury to be seen and treated as soon as possible to avoid any lasting pain or other issues,” Dr. Badia says. “Our everyday movements require fully functional wrists, so don’t ignore wrist injuries.”

Bio: Alejandro Badia, MD, FACS, is an internationally renowned hand and upper-limb surgeon and founder of Badia Hand to Shoulder Center and OrthoNOW®, a network of walk-in orthopedic centers. Dr. Badia is the author of Healthcare from the Trenches. http://www.drbadia.com http://www.orthonowcare.com

Share article on social media or email:

Ziegler Serves As Exclusive Capital Structuring Advisor On Acquisition Of Senior Housing Portfolio


“We are thrilled to have been able to secure the debt needed for Radiant to complete this acquisition in a timely manner during a difficult lending period in the market,” stated Eric Johnson, Senior Vice President in Ziegler’s Senior Housing & Care Finance practice…

Ziegler, a specialty investment bank, is pleased to announce its role as exclusive capital structuring advisor in a $42,600,000 debt placement (the “Financing”) on behalf of Radiant Senior Living (Radiant) to finance the acquisition of a portfolio of three senior housing communities located in Washington and Montana (the “Portfolio”). Two of the communities are located in Washington near Seattle, while the third is located in Bozeman, Montana.

“We are thrilled to have been able to secure the debt needed for Radiant to complete this acquisition in a timely manner during a difficult lending period in the market,” stated Eric Johnson, Senior Vice President in Ziegler’s Senior Housing & Care Finance practice, who arranged and negotiated the transaction.

The Financing consisted of a combination of senior and mezzanine debt, with Congressional Bank providing the senior debt and a national senior housing fund providing the mezzanine debt.

“We were pleased to have been selected to provide the senior debt for this transaction. We have been looking for the right opportunity to provide financing for Radiant, a best-in-class owner/operator. We are extremely thankful to the Ziegler team for showing us the transaction and for facilitating such a smooth process,” said Amy Heller, President of Healthcare Lending at Congressional.

Radiant acquired the Portfolio from a publicly traded healthcare REIT as part of their expansion efforts across the country. The Portfolio consists of 36 independent living units and 204 assisted living units. The properties enjoy in-place, stabilized cash flow and provide opportunity for additional upside through operational efficiencies due to scale. Post-acquisition, Radiant’s portfolio totals 18 communities spanning across six states in the Pacific Northwest.

Ziegler’s Senior Housing & Care Finance Practice brings its experience and expertise to senior housing and post-acute care clients. By offering a comprehensive suite of products for debt, equity and M&A services, our professionals provide creative solutions that meet your organization’s capital goals.

For more information about Ziegler, please visit us at http://www.ziegler.com.

About Ziegler:

Ziegler is a privately held, national boutique investment bank, capital markets and proprietary investments firm. It has a unique focus on healthcare, senior living and education sectors, as well as general municipal and structured finance. Headquartered in Chicago with regional and branch offices throughout the U.S., Ziegler provides its clients with capital raising, strategic advisory services, fixed income sales, underwriting and trading as well as Ziegler Credit, Surveillance and Analytics. To learn more, visit http://www.ziegler.com.

Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client’s experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.

# # #

Share article on social media or email:

Adaptilens Announces $1.6 Million in Seed Funding to Revolutionize the Way Vision is Corrected


Adaptilens

Today, Adaptilens announced a $1.6 million seed funding led by Pillar VC with additional participation from Accanto Partners to fund the company’s development of an innovative accommodating intraocular lens with the aim of allowing patients to live their lives free of glasses and contact lenses.

The company’s mission is to restore patients’ sight to a youthful, natural, continuous range of vision. Adaptilens’ flexible intraocular lens mimics the natural human lens, giving patients clear near, intermediate, and distance vision, by allowing the eye’s ciliary muscles to change the implanted lens’ shape, so that the eye can focus at a range of distances naturally.

Initially, the AdaptilensTM will be used for patients undergoing cataract surgery. According to the National Eye Institute, by 2050, the number of people with cataracts in the U.S. is expected to double from 24.4 million to approximately 50 million.* Each year, doctors in the U.S. perform about 4 million cataract surgeries, typically removing the cataractous lens and replacing it with a flat, monofocal lens that allows the patient to see clearly at distance or near, but not both.** This leaves many patients still dependent on glasses, a nuisance and risk for the patient. Adaptilens aims to solve this problem by developing a shape-changing, accommodating intraocular lens that allows patients to see clearly at multiple distances.

“Adaptilens is delighted to be partnering with Pillar and Accanto. We’re confident that with their strength and resources, we will be able to advance our technology rapidly and efficiently so that we can improve the quality of life for millions of people,” says Dr. Liane Clamen, Adaptilens’ Founder and CEO. “For decades, doctors have been replacing nature’s full, flexible lens with a flat, stiff lens. We are determined to provide a better solution by developing a flexible lens that lets the eye’s muscles of accommodation naturally change its shape, and allow people to see clearly at near, intermediate, and far distances.”

While this innovative lens will initially be used for patients with cataracts, the AdaptilensTM could also be used to correct the vision of patients with a variety of refractive errors. For example, the AdaptilensTM could be used for patients with presbyopia, which is the loss of near vision caused by decreased elasticity of the eye’s lens, typically occurring in middle age. Patients with presbyopia could achieve spectacle independence with the AdaptilensTM.

“The biggest challenge in solving age-related loss of near vision has been the difficulty of creating a lens that will respond to the eye’s natural signal to focus. We are developing a unique solution to maintain a person’s ability to see clearly and naturally at both distance and near by regaining intrinsic accommodation,” says Dr. Bonnie Henderson, Adaptilens Co-developer and Chair of its Scientific Advisory Board.

“We are thrilled to be partnering with the Adaptilens team to bring their innovative corrective eye technology to market,” says Jamie Goldstein, Founder and Partner at Pillar VC. “At Pillar, we look to support visionary technologies, which applies here in more ways than one. The Adaptilens technology accomplishes this through their innovative intraocular lens that mimics the natural lens, something not achieved by current corrective eye surgeries.”

The inspiration for the AdaptilensTM came when Dr. Clamen was asked to write a textbook chapter about the history of the intraocular lens. After exhaustively researching artificial lenses, Dr. Clamen discovered that no one had succeeded in developing a lens that truly imitated the natural lens. Seeing a huge opportunity for an unmet need among the visually impaired, Dr. Clamen partnered with renowned materials scientists to develop a new material that would allow for the development of a true, shape-changing, accommodating lens.

To find out more about Adaptilens please visit: http://www.adaptilens.com

*https://www.nei.nih.gov/learn-about-eye-health/resources-for-health-educators/eye-health-data-and-statistics/cataract-data-and-statistics

**https://idataresearch.com/over-3-8-million-cataract-surgeries-performed-every-year/

About Adaptilens:

Adaptilens was founded in 2019 by Harvard-trained ophthalmologist Dr. Liane Clamen. The company’s mission is to revolutionize the way vision is corrected by developing an accommodating intraocular lens that mimics the natural human lens so that patients will have excellent near, intermediate, and distance vision without the need for eyeglasses or contact lenses. To find out more about Adaptilens please visit: http://www.adaptilens.com

About Pillar VC:

Pillar VC is a seed-stage venture firm in Boston co-founded by 22 CEOs, including the leaders of Ginkgo Bioworks, Iora Health, Cytyc, DraftKings, and Wayfair. The firm’s investments include PillPack, Desktop Metal, Kuebix, Algorand, Asimov, and PathAI, among others. Pillar believes that the strongest relationships start from a position of trust, and that VC doesn’t have to be the dark side. The firm aligns with founders by providing resources and support, and by offering to buy common stock –– the very same type of stock founders own. To find out more about Pillar VC please visit: http://www.pillar.vc

About Accanto Partners:

Accanto Partners LLC invests selectively in promising tech startups. Based in Tiburon, CA, Accanto was founded by successful entrepreneurs and executives formerly with Sonic Solutions, an early leader in digital media technologies that was acquired by Rovi (now Tivo) in 2011. Given Accanto’s roots, the company prides itself on the entrepreneurial viewpoint it brings to each of its investments. Accanto generally invests in a startup’s first professional financing round, aims to provide thoughtful support to founders as they grow their companies, and in most cases participates as well in all subsequent funding rounds. To find out more about Accanto Partners please visit: http://www.accantopartners.com

Share article on social media or email:

Introducing Safr Care, New Rideshare for Non-Emergency Medical Transportation


Safr Care Logo

“Safr Care is a new non-emergency rideshare service catering to patients who face barriers in getting to routine medical appointments, which are often crucial to maintaining their health and well-being.” —Syed Gilani, CEO, Safr

Safr, a new rideshare for the safety and empowerment of women, has unveiled Safr Care, a new non-emergency medical transportation service providing patients, healthcare consumers and medical professionals a safe and effective non-emergency transportation solution. Syed Gilani, CEO of Safr, made the announcement.

“Safr Care is a new non-emergency rideshare service catering to patients who face barriers in getting to routine medical appointments, which are often crucial to maintaining their health and well-being,” Mr. Gilani stated. “The field of non-emergency medical transportation lacks a seamless, unified technological backbone to manage reliable transportation for patients and Medicaid members. Whether due to income, lack of adequate or accessible public transportation, or conditions which require frequent and regular appointments, patients’ needs are not being served by the current transportation landscape. Safr Care is a solution to this nationwide problem, and looks forward to serving patients and healthcare consumers and improving the non-emergency medical transportation experience for all.”

Today, over three-quarters of all healthcare spending nationally is for chronic health problems such as arthritis, asthma, cancer, cardiovascular disease, chronic obstructive pulmonary disease and diabetes, which require ongoing treatment; 78% of the adult population over age 55 has at least one of these conditions. According to the U.S. Census Bureau, by 2035 there will be a booming senior population, with a projected 78 million people aged 65 years and older.

Lack of reliable transportation is particularly problematic for those facing disability, illness, and ongoing medical issues. Other barriers may include the inability to drive or lack of vehicle access. Non-emergency medical transportation ensures patients attend ongoing medical care appointments, which are vital to patients’ health and wellness.

Safr Care is a solution for a growing sector of people in need of quality non-emergency medical transportation. Using proprietary rideshare technology, Safr Care links hospitals and Medicare/Medicaid patients with seamless door-to-door service. Alleviating stress and complications for both medical providers and patients looking for accessible and affordable non-emergency medical transportation is the mission of Safr Care.

Safr is a new rideshare all about empowering women riders and drivers. The app is free and easy to use, available to download for iPhone here: https://apps.apple.com/us/app/ride-safr/id1151088240?ls=1 and for Android here: https://play.google.com/store/apps/details?id=com.tgi.safeher.passenger.

About Safr

Safr is a new ridesharing service focused on the safety and empowerment of women. Built with the needs of women in mind, Safr aims to improve the lives of women everywhere through safe transportation, job creation, and financial security. Safr’s drivers are personally vetted and undergo comprehensive background checks so that riders can have peace of mind knowing they meet Safr standards. Safr’s multiple in-ride app features aid in the protection of your safe arrival. When you choose to ride with Safr, you’re supporting a like-minded driver and elevating your community by helping to improve greater gender balance, choice, and participation in the ridesharing economy. For more information, please visit http://www.gosafr.com.

Share article on social media or email:

HMP Global Announces Agenda for 3rd Annual Cocaine, Meth & Stimulant Summit


News Image

“The Cocaine, Meth & Stimulant Summit provides an extensive educational experience for professionals on the frontlines of this rising epidemic,” said Doug Edwards, Director, HMP’s Psychiatry & Behavioral Health Learning Network.

As the nation continues to experience an uptick in the misuse of prescription and illicit stimulants, HMP Global, a leader in healthcare events and education and producer of the annual Rx Drug Abuse & Heroin Summit, has announced the third annual Cocaine, Meth & Stimulant Summit will take place virtually from November 20-22, 2020.

This comprehensive meeting is the country’s only educational event providing clinical, law enforcement, and public safety professionals with practical strategies and solutions to address the national stimulant crisis. The Summit will bring together key stakeholders to discuss strategies to prevent illicit stimulant abuse, provide access to treatment, and ensure that stimulants are part of larger societal discussions about addressing drug use. Attendees will have the unique opportunity to engage with an array of accomplished field leaders and industry experts with pervasive knowledge of this ongoing crisis, which continues to be an often underrecognized emergency compounding the opioid epidemic.

Notably, nearly 2.2 million individuals currently use cocaine while 6 million misuse prescription stimulants. Despite these staggering statistics, there are not currently any medications approved by the U.S. Food and Drug Administration (FDA) to treat stimulant use disorder.

Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) will deliver the Summit’s Keynote Address Friday, November 20 at 4:45 pm EST and discuss the rise of stimulant misuse in the United States. Also slated to speak at the event is Kemp L. Chester, MA, Associate Director of the White House Office of National Drug Control Policy (ONDCP) who will present “Coordinating Federal Response to the 21st Century Illicit Drug Marketplace – Stimulants Surge” November 20 at 11:15 am. A timely panel discussion focused on COVID-19 and stimulant use will be held November 21 at 3:15 pm to review the unique challenges treatment providers currently face during the coronavirus pandemic and methods to overcome such obstacles.

“The growing national stimulant crisis highlights the need for ongoing education and engagement regarding this emergency,” said Doug Edwards, Director, HMP’s Psychiatry & Behavioral Health Learning Network. “As such, the Cocaine, Meth & Stimulant Summit provides a fundamental and extensive educational experience for professionals on the frontlines of this rising epidemic as we collaborate toward solutions and change. Industry leadership and experts will provide crucial, in-depth perspectives to identify practical strategies in a valuable multi-disciplinary approach.”

This year’s Summit features a clinical track as well as a law enforcement/public safety track, catering to the various players involved in fighting this epidemic. Attendees can earn up to 25 CE credits at the Summit. Organizations supporting the conference include the South Florida High Intensity Drug Trafficking Area (SFHIDTA), the National Safety Council, and the National HIDTA Program Emerging Threats Initiative.

For more information, visit http://www.stimulantsummit.com. For media inquiries, contact Kelly McCurdy at pr@hmpglobal.com.

ABOUT HMP GLOBAL

HMP Global is the force behind Healthcare Made Practical – and is a multichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant360, the year-round, award-winning platform relied upon by primary care providers and other specialists; Psych Congress, the largest independent mental health meeting in the U.S.; Rx Drug Abuse & Heroin Summit, the largest annual gathering on the opioid crisis; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

Share article on social media or email:

Regency Palms Oxnard Assisted Living and Memory Care to Open in Mid-January 2021


Bistro Lounge

This one-of-a-kind option for the Oxnard area is sure to elevate the spirits of the seniors we’ll serve by offering a vibrant and exceptional community culture for both them and their family members.

Regency Palms Oxnard Assisted Living and Memory Care, a luxurious, beautifully renovated senior living community in Oxnard, CA, is expected to welcome new residents starting in mid-January 2021. Now under construction led by Urban Community Builders, this vibrant 101-suite community will offer compassionate assisted living services and a distinctive dementia care program based on a Montessori methodology for seniors with Alzheimer’s or other forms of dementia in the Ventura County, CA area.

During construction, Regency Palms Oxnard is offering limited spots to residents who want to be recognized as charter members who are granted exclusive benefits and lucrative savings. Seniors and their families can learn the specific savings and benefits options of enrolling in the exclusive Charter Membership Program by calling the community at (805) 342-2001.

Regency Palms Oxnard offers 65 assisted living and 36 memory care suites ranging from cozy studios to luxury one-bedroom suites in a single-story, 34,000 square foot building. Nestled in a quiet residential area, Regency Palms Oxnard is thoughtfully redesigned to include customized room designs with extra storage and vistas of beautifully landscaped outdoor areas. Each of the nine outdoor courtyards have a unique design to enrich outdoor recreation. This amenity-rich building supports the community’s focus on active living: daily engaging and social activities, a dining experience with multiple dining options and venues, as well as an exceptional level of care. All spaces of the building have been carefully appointed to accommodate the superior services and luxurious lifestyle residents at Regency Palms Oxnard deserve, at a price within reach.

“We couldn’t be more thrilled to kick-start the New Year opening Regency Palms Oxnard and welcome residents to their new home,” stated Glen Cummins, Regional Director of Operations. “This one-of-a-kind option for the Oxnard area is sure to elevate the spirits of the seniors we’ll serve by offering a vibrant and exceptional community culture for both them and their family members.”

Managed by national senior housing operator Meridian Senior Living, LLC, Regency Palms Oxnard will offer to its residents daily social activities such as discussion groups, exercise classes, films, baking, gardening, music, and art; all led by a dedicated Life Engagement Coordinator. In addition to delivering compassionate care, Regency Palms Oxnard features Montessori Moments in Time™ memory care programming, Revolution in Motion exercise and mobility program, Music and Memory program, scheduled transportation to appointments and outings, housekeeping and laundry services, assistance with daily living and medication management, 24 hours /7 days a week on-site care services, and more. As Regency Palms Oxnard’s leadership team navigates the ongoing crisis, all community activities will be conducted in the safest possible manner while creating the best achievable environment where residents will thrive.

Upon opening, Regency Palms Oxnard will host an exciting Grand Opening celebration open to the public featuring tailored tours, exciting prize giveaways, live entertainment, delicious food and refreshments, and very special move-in incentives for depositors at the community at 1020 Bismark Way in Oxnard. To ensure that all interested parties can attend and tour the community, while keeping safe, the Grand Opening will occur over a span of four days.

To learn more about Regency Palms Oxnard, visit regencypalmsoxnard.com or call (805) 342-2001.

About Meridian Senior Living:

Meridian Senior Living, a privately held company based in Bethesda, Maryland, owns and operates seniors housing communities across the country and provides operational consulting to 24 communities in China. With more than 75 communities in 21 states and more in development, Meridian is one of the largest seniors housing operators in the U.S. The company prides itself on providing the highest quality care, exceptional lifestyle programming and a distinctive dining experience for its residents. For more information on Meridian Senior Living, visit meridiansenior.com.

Share article on social media or email:

What Do Consumers Want? (They Told Us)


consumers increasingly look for foods and beverages that deliver functionality and support their wellness goals

Holistic wellbeing is a long-term trend that is top of mind for consumers. COVID-19 has accelerated this trend and motivated individuals to find ways to make themselves stronger, physically and mentally. As a result, consumers increasingly look for foods and beverages that deliver functionality and support their wellness goals. As part of our Wellness in a Bottle Series, this webinar will expand on Givaudan’s proprietary consumer insights on functional beverages to explore shoppers’ connections between beverages, health benefits, flavors, and ingredients. We have identified the opportunities to create functional products that will win in the market.

Join expert speakers from Givaudan, Santiago Vega, Director of Marketing – Naturex; Chuck Wareing, Senior Scientist, Flavor Creation and Applications – Beverage Group; Savannah Turner, Marketing Beverage Expert; and Annaliese Hnat, Category Marketing Manager, in a live webinar on Tuesday, December 1, 2020 at 1pm EST.

For more information, or to register for this event, visit Wellness in a Bottle Series: What Do Consumers Want? (They Told Us).

ABOUT GIVAUDAN

Powered by innovation and creativity, Givaudan Taste & Wellbeing aims to shape the future of food by becoming the co-creation partner of choice to its customers. Built on its global leadership position in flavours and taste, the Company goes beyond to create food experiences that do good and feel good, for body, mind and planet.

With an expanded portfolio of products across flavours, taste, functional and nutritional solutions and a deep knowledge of the food ecosystem, Givaudan’s passion is to collaborate with customers and partners to develop game-changing innovations in food and beverage. Let’s imagine together the future of food.

Learn more at http://www.givaudan.com/taste-wellbeing

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Sydney Perelmutter

Tel: +1 (416) 977-6555 x 352

Email: sperelmutter@xtalks.com

Share article on social media or email:

How to Maximize Pharmaceutical Supply Chain Efficiency and Security From Manufacturer to Patient, Upcoming Webinar Hosted by Xtalks


As the pharmaceutical industry continues to adapt to the new challenges and increasing demand for transparency, companies must also equip themselves with the tools to meet expectations while maximizing operational efficiency.

In these uncertain times, everyone from manufacturers to patients needs to think about the safety and security of pharmaceutical products. As the pharmaceutical industry continues to adapt to the new challenges and increasing demand for transparency, companies must also equip themselves with the tools to meet expectations while maximizing operational efficiency.

In this exclusive webinar, Optel’s experts will explore the issues surrounding efficiency and security in the pharmaceutical supply chain and propose solutions to ensure both.

Optel has developed two exceptional and complementary tools as part of its modular and scalable Intelligent Supply Chain® platform, which has been carefully built to provide full transparency along every step of the supply chain. Both will be presented during the webinar.

The first is Verify Platform, a powerful software program designed to increase efficiency and security at the manufacturing, distribution and healthcare levels of the supply chain. The second is the Production Efficiency Tool, designed to optimize manufacturing operations.

Join expert speakers from OPTEL, Guillaume Frapsauce, Account Director; Frédéric Bertiaux, Solution Designer; and Chad Owens, Director of Technology – Digitization Solutions, in a live webinar on Wednesday, December 2, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, How to Maximize Pharmaceutical Supply Chain Efficiency and Security From Manufacturer to Patient.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Creating Efficiency with Metadata-Driven End-to-End Standards, Upcoming Webinar Hosted by Xtalks


The panelists will also show how through these standards they were able to decrease their effort per unit for various tasks in the process, and will offer recommendations for how the attendees can achieve similar benefits through their end-to-end standards implementations.

The FDA and PMDA are now requiring standardized study data in submissions. PRA Health Sciences has worked to create metadata-driven end-to-end standards to comply with these regulatory requirements and to drive efficiency, consistency and quality of its delivery.

In this webinar, panelists from PRA will demonstrate, through a case study, how they have defined end-to-end standards as interconnected metadata and developed automations to create Case Report Forms, SDTM, and ADaM data sets and tables, figures, and listings. The panelists will also show how through these standards they were able to decrease their effort per unit for various tasks in the process, and will offer recommendations for how the attendees can achieve similar benefits through their end-to-end standards implementations.

Join experts from PRA Health Sciences for the live webinar on Wednesday, December 2, 2020 at 11 a.m. EST / 4 p.m. GMT:

  • Kent Letourneau, Executive Director, Global Data Standards
  • Hansjörg Frenzel, Senior Principal Clinical Data Standards Consultant
  • Maria Sekac, Senior Principal Clinical Data Standards Consultant

To register for this event, visit – Creating Efficiency with Metadata-Driven End-to-End Standards.

ABOUT PRA HEALTH SCIENCES

PRA Health Sciences is one of the world’s leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes more than 75 offices across North America, Europe, Asia, Latin America, Africa, Australia and the Middle East and more than 17,500 employees worldwide. Since 2000, PRA has participated in approximately 4,000 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 95 drugs. To learn more about PRA, please visit http://www.prahs.com.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Mind the Gap! The EU IVDR Deadline Is More Than a Regulatory Issue, Upcoming Webinar Hosted by Xtalks


Overcome your timeline and revenue risks via a tested, fit-for-purpose solution comprised of regulatory oversight, standardized templates for technical documentation and literature search, compliant data capture and core lab capabilities to address all your IVDR needs.

The In Vitro Diagnostic Regulation (IVDR) greatly increases the number of in vitro diagnostic (IVD) devices subject to rigorous oversight and expands the scope of compliance. It brings European regulation into closer harmonization with the global classification for IVD devices that has been around for many years.

With increased requirements that include regulatory review by notified bodies, more clinical performance and evidence studies, peer reviewed literature searches and extended post marketing surveillance, many diagnostic companies are struggling with compliance in time to meet the looming May 2022 deadline, and particularly when they learn that their MDR data won’t suffice for IVDR.

Quartesian, Corgenix and their medical device partners have formed a consortium of domain experts to assess the IVDR requirements for existing devices and execute any steps necessary for compliance. Overcome your timeline and revenue risks via a tested, fit-for-purpose solution comprised of regulatory oversight, standardized templates for technical documentation and literature search, compliant data capture and core lab capabilities to address all your IVDR needs.

Join Dr. Kelly R. Pitts, President and Chief Scientific Officer, Corgenix, Inc.; and Stephen Boccardo, SVP Business Development and Commercial Strategy, Quartesian, in a live webinar on Tuesday, November 17, 2020 at 1pm EST (10am PST).

For more information, or to register for this event, visit Mind the Gap! The EU IVDR Deadline Is More Than a Regulatory Issue.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: